Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Bial-portela & Ca. S.A.

Headquarters: S. Mamede do Coronado, Portugal
Year Founded: 1924
Status: Private

BioCentury | Aug 2, 2018
Tools & Techniques

Model firsts

How quantitative systems pharmacology can pick the right dose for first-in-human trials
BioCentury | Jan 12, 2018
Company News

Fosun gets Chinese rights to Bial's PD drug

BioCentury | Oct 20, 2017
Clinical News

FDA approves sNDA for Sunovion's Aptiom

BioCentury | Mar 29, 2017
Clinical News

Zebinix regulatory update

BioCentury | Mar 14, 2017
Clinical News

Aptiom regulatory update

BioCentury | Feb 16, 2017
Company News

Bial-Portela, Neurocrine Biosciences deal

BioCentury | Feb 10, 2017
Company News

Neurocrine gets rights to Bial-Portela's PD drug

Items per page:
1 - 10 of 76